Symrise Ag · XETR:SY1

Symrise — Symrise Ag Ord — FY 2025 Earnings Presentation

31 slides from Symrise's earnings presentation, Mar 4, 2026

  1. Slide 1: Financial Results Full Year 2025

    Financial Results Full Year 2025 — Dr. Jean-Yves Parisot (CEO), Olaf Klinger (CFO) 04 March 2026

  2. Slide 2: Agenda

    Agenda Overview — 1 2 3 4 Highlights Financials Strategy 2026 2025 2025 Update Outlook Dr. Jean-Yves Parisot, CEO Olaf Klinger, CFO 2

  3. Slide 3: Highlights 2025

    01 Highlights 2025 3

  4. Slide 4: 2025 Highlights

    2025 Highlights HIGHLIGHTS 2025 Delivered solid organic sales growth and strong profitability — Sales 1 Outperformed market growth, particularly in Flavor & Fragrance €4,929m -1.4% year-on-year +2.8% Organic sales growth Adjusted EBITDA Continued to drive profitability; 2 delivered €50m in cost savi

  5. Slide 5: FY 2025 Sales by Segment

    FY 2025 Sales by Segment HIGHLIGHTS 2025 Outperforming in Food & Beverages with continued momentum in Fragrance — Taste, Nutrition & Health Scent & Care ~€3,028m 2.6% ~€1,901m 3.2% Reported sales Organic sales growth Reported sales Organic sales growth Food & Beverage Pet Food Fragrance Cosmetic Ing

  6. Slide 6: FY 2025 Sales by Region

    FY 2025 Sales by Region FINANCIALS 2025 Solid regional organic sales growth, with outperformance in Latin America — and good momentum in EAME and Asia Pacific Organic sales growth by region Sales by region % of global sales 21% 25% North America +0.4% FY €4,929m Asia FY Pacific 13% EAME +3.2% FY +2.

  7. Slide 7: Financials 2025

    02 Financials 2025 7

  8. Slide 8: Q4 2025: Sales Performance

    Q4 2025: Sales Performance FINANCIALS 2025 Market-leading growth in Food & Beverage, strong performance in Fragrance — Group Taste, Nutrition & Health Scent & Care In €m In €m In €m -1.8% 1,175 +3.6% -0.2% -5.2% 1,153 -3 -3.7% 42 -61 742 +2.5% -0.3% -5.9% 714 1.3% 18 -3 -43 433 +5.5% 0.0% -4.2% 439

  9. Slide 9: Group: FY 2025 Financial Performance

    Group: FY 2025 Financial Performance FINANCIALS 2025 Above-market organic sales growth and strong margin expansion — Sales Sales (in €m) • Organic growth of 2.8% +2.8% -0.3% -3.9% -1.4% • Strategic divestments: 4,999 -16 4,929 ‒ Aqua Feed business and 51% of UK 140 -194 trading business, aligned wit

  10. Slide 10: Taste, Nutrition & Health: FY 2025

    Taste, Nutrition & Health: FY 2025 FINANCIALS 2025 Outperforming F&B market growth with leading profitability — of 23.8% Organic Sales Growth Sales (in €m) • Food & Beverage (F&B): ‒ Industry-leading mid single-digit growth, +2.6% -0.5% -4.1% despite strong comparables; high single- 3,091 -16 digit

  11. Slide 11: Scent & Care: FY 2025

    Scent & Care: FY 2025 FINANCIALS 2025 Healthy growth and solid margin expansion — Organic Sales Growth Sales (in €m) • Fragrance: high single-digit growth ‒ Fine Fragrances: high single-digit growth -0.3% with new wins in NA and LATAM 1,908 +3.2% -3.5% 1,901 ‒ Consumer Fragrances: high single-digit

  12. Slide 12: Group: FY 2025 Profitability

    Group: FY 2025 Profitability FINANCIALS 2025 Strong profitability uplift driven by €50m sales and cost savings and efficiency — gains in € million FY 2024 FY 2025 Adj. FY 20251 Change (%) • Gross Profit and EBITDA margin Sales 4,999 4,929 4,929 -1.4 expansion driven by product mix Gross profit 1,963

  13. Slide 13: Group: FY 2025 Business Free Cash Flow (BFCF)

    Group: FY 2025 Business Free Cash Flow (BFCF) FINANCIALS 2025 Disciplined execution driving robust cash flow generation with — consistent year-on-year progress BFCF (in €m) +14.6% 780 680 553 • Record adjusted BFCF margin 301 improved 220 bps year-on-year driven by EBITDA uplift, lower CapEx intensi

  14. Slide 14: Group: FY 2025 Balance Sheet and Net Debt

    Group: FY 2025 Balance Sheet and Net Debt FINANCIALS 2025 Proven financial strength supports disciplined capital allocation — Balance Sheet FY 2024 FY 2025 Cash and Cash Equivalents €709m €1,010m • Net debt (including pension Equity Ratio1 48.3% 47.3% provisions and leasing obligation): €2,088m or 1

  15. Slide 15: Capital Allocation Priorities

    Capital Allocation Priorities FINANCIALS 2025 — • High-return investments that scale existing 1 Organic Investment capabilities to augment growth • Mid-term CapEx target: 4–5% of sales Maintain • Prudent and disciplined M&A strategy: Investment-grade 2 Value-Accretive M&A 1) foster long-lasting, abo

  16. Slide 16: Group: Shareholder Value

    Group: Shareholder Value FINANCIALS 2025 Enhancing shareholder value through resilient earnings, a —growing dividend and share buybacks Earnings per Share (in €) 3.42 +7.2% 3.67 16th consecutive dividend 2.91 increase: €1.25 proposal 2.44 • Driving shareholder value through sustainable dividend grow

  17. Slide 17: Strategy Update

    03 Strategy Update 17

  18. Slide 18: Executing Our ONE Symrise Strategy and ONE SYM Transformation

    Executing Our ONE Symrise Strategy and ONE SYM Transformation STRATEGY UPDATE Sharpening our competitive edge — ONE Symrise Strategy ONE SYM Transformation PLANNED INNOVATE IN HEALTH, WELLBEING AND BEAUTY, PURPOSE FOR THE ENTIRE FAMILY’S EVERYDAY LIFE ACTIVE Phase 3: COMPLETED Drive WHERE PORTFOLIO:

  19. Slide 19: Advancing Our Strategy and Driving Organizational Change

    Advancing Our Strategy and Driving Organizational Change STRATEGY UPDATE Achieved significant milestones with already visible results — 2024-2025 Accomplishments Delivered €100m cumulative cost Completed strategic assessment Laid groundwork for future savings and efficiency gains while of chemicals

  20. Slide 20: Accelerating Our ONE SYM Transformation

    Accelerating Our ONE SYM Transformation STRATEGY UPDATE Broad acceleration enables continued reinvestment to drive long-term, profitable growth — PLANNED ACTIVE COMPLETED Phase 3: Future Phase 2: Q2 2025 Drive Momentum & Activate & Start Deliver Performance Phase 1: April 2024 – Q1 2025 Delivering i

  21. Slide 21: Aligning Portfolio to Customer Needs

    Portfolio Aligning Portfolio to Customer Needs STRATEGY UPDATE Creating new beauty & health-focused division to New Care & Wellness Division deliver — science-led, holistic solutions • Launched January 1, 2026; formerly Taste, Nutrition & Health Scent & Care ONE Care Food & Care & Aroma • Creates un

  22. Slide 22: Driving Durable, Profitable Growth

    Growth & Efficiency Driving Durable, Profitable Growth STRATEGY UPDATE Maintaining rigorous cost discipline while continuing to fund strategic reinvestment — 2026-2028 priorities Focus areas to enhance competitiveness Drive Commercial Improving processes and tools; implementing Excellence sales and

  23. Slide 23: 2026 Outlook

    04 2026 Outlook 23

  24. Slide 24: FY 2026 Outlook and Mid-Term Targets

    FY 2026 Outlook and Mid-Term Targets 2026 OUTLOOK — 2026 Outlook Mid-term Targets (2025-2028) Organic growth 2%-4% 5%-7% (CAGR) EBITDA margin 21.5%-22.5% (Adjusted) 21%-23% BFCF margin >14% (Adjusted) >14% Commentary • The full-year 2026 outlook assumes Q1 organic • Multi-year growth opportunities g

  25. Slide 25: Closing Remarks

    Closing Remarks Controlling the controllables while executing ONE Symrise Strategy and — accelerating multi-year ONE SYM Transformation 1 2 3 Enhance Drive durable, Increase competitiveness profitable growth shareholder value through the across all our through resilient acceleration of the businesse

  26. Slide 26: Symrise AG Contact

    Symrise AG — Financial calendar Contact 29 April Symrise AG Q1 Trading Statement 2026 Muehlenfeldstraße 1 37603 Holzminden, Germany 30 July Half Year Results 2026 René Weinberg Investor Relations 28 October rene.weinberg@symrise.com Q3 Trading Statement 2026 This document contains forward-looking st

  27. Slide 27: Appendix

    Appendix 27

  28. Slide 28: Adjustment details

    Adjustment details Further details to be provided in the annual report chapter 4.6 — 2022: Adjustment made for the impairment of Swedencare AB, Malmö, Sweden. 2023: Adjustments were made for the costs in connection with the production stoppage at the Colonel Island site, the costs of the reorganizat

  29. Slide 29: Sales by Region in Q4 2025

    Sales by Region in Q4 2025 FINANCIALS 2025 Solid regional organic sales growth, with outperformance in Latin America — and Asia Pacific Organic sales growth by region Sales by region % of revenue % of global sales 21% 26% €1,153m North America Q4 +5.9% Q4 13% Asia Pacific 40% EAME +5.3% Q4 -0.1% Q4

  30. Slide 30: Glossary

    Glossary — APAC Asia Pacific BFCF Business Free Cash Flow DD Double digit EAME Europe, Africa, Middle East FX Foreign exchange HSD High single digit LATAM Latin America LSD Low single digit LTM Last twelve months MSD Mid single digit NA North America OSG Organic sales growth 30

  31. Slide 31: symrise

    ry symrise always inspiring more

Symrise Ag Ord — FY 2025 Earnings Presentation on 6ix